| 111.15 -12.12 (-9.83%) | 04-25 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 138.57 |
1-year : | 144.82 |
| Resists | First : | 118.64 |
Second : | 123.98 |
| Pivot price | 117.16 |
|||
| Supports | First : | 109.99 |
Second : | 91.51 |
| MAs | MA(5) : | 117.12 |
MA(20) : | 116.8 |
| MA(100) : | 106.01  |
MA(250) : | 92.41 |
|
| MACD | MACD : | 1.1 |
Signal : | 1.5 |
| %K %D | K(14,3) : | 50.8 |
D(3) : | 52.3 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 123.98 | Low : | 69.4 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ITGR ] has closed below the lower bollinger band by 8.3%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ ITGR ] is to continue within current trading range. Bollinger Bands are 10.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 120.07 - 120.68 | 120.68 - 121.15 |
| Low: | 108.66 - 109.26 | 109.26 - 109.72 |
| Close: | 110.19 - 111.21 | 111.21 - 111.98 |
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Thu, 25 Apr 2024
Integer stock sinks despite Q1 beat as full-year forecast disappoints - Mass Device
Thu, 25 Apr 2024
Integer (ITGR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Canada Finance
Thu, 25 Apr 2024
Integer Holdings Corp (ITGR) Q1 2024 Earnings: Surpasses Analyst Revenue Forecasts and EPS ... - Yahoo Finance
Thu, 25 Apr 2024
Integer (ITGR) Q1 Earnings and Revenues Top Estimates - Zacks Investment Research
Thu, 25 Apr 2024
Integer Holdings Updates Q1 Earnings Presentation Online - TipRanks.com - TipRanks
Thu, 25 Apr 2024
Integer Holdings Corporation Reports First Quarter 2024 Results - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 34 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 1.5 (%) |
| Held by Institutions | 111.1 (%) |
| Shares Short | 2,430 (K) |
| Shares Short P.Month | 2,430 (K) |
| EPS | 2.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 45.58 |
| Profit Margin | 5.6 % |
| Operating Margin | 12.5 % |
| Return on Assets (ttm) | 3.9 % |
| Return on Equity (ttm) | 6.1 % |
| Qtrly Rev. Growth | 10.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 47.76 |
| EBITDA (p.s.) | 8.41 |
| Qtrly Earnings Growth | 44.2 % |
| Operating Cash Flow | 180 (M) |
| Levered Free Cash Flow | 48 (M) |
| PE Ratio | 41.31 |
| PEG Ratio | 1.6 |
| Price to Book value | 2.43 |
| Price to Sales | 2.32 |
| Price to Cash Flow | 20.66 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|